CMS issues proposed decision memorandum for screening for cervical cancer with testing
Physician Practice Insider, May 5, 2015
On April 16, CMS posted a proposed decision memorandum stating evidence is sufficient to add Human Papillomavirus (HPV) testing once every five years as an additional preventive service benefit under the Medicare program for asymptomatic beneficiaries aged 30 to 65 years in conjunction with the pap smear test. CMS will cover screening for cervical cancer with the appropriate FDA-approved/cleared laboratory tests, used consistent with FDA-approved labeling and in compliance with the CLIA regulations.
View the proposed decision memorandum.
This article originally appeared in Medicare Weekly Insider.
Related Products
Most Popular
- Articles
-
- Note similarities and differences between HCPCS, CPT® codes
- Joint Commission clarifies ligature risk requirements
- 3 ways CNOs can improve workplace culture
- Don't forget the three checks in medication administration
- Practice the six rights of medication administration
- What to include on the incident report
- OB services: Coding inside and outside of the package
- Q&A: Primary, principal, and secondary diagnoses
- Understanding nursing roles in quality improvement
- Code diagnoses and outpatient treatment for PTSD
- E-mailed
-
- Tip: Coding for cancer
- Suicide prevention NPSG now applies to Critical Access Hospitals
- Prioritize sepsis assessments in your overcrowded emergency department
- OB services: Coding inside and outside of the package
- Joint Commission clarifies ligature risk requirements
- Don't bill 59025, 76818 separately without separate physician orders
- Crossing state lines: What are the rules?
- 3 ways CNOs can improve workplace culture
- Searched